Topic
Psychedelics
90 published works
Cannabis Law Blog
Updates on Michigan Psychedelic News
It’s been an active few weeks in Michigan on the psychedelics front, with activity on both the legalization and law enforcement sides of the issue. Here’s a quick recap of…
Cultiva Law Blog
VISIONS Act & The Future of Psychedelics
By Aaron Pelley
As cannabis legalization and further medical implementation of the cannabis plant becomes more legal and accessible, the discussion surrounding the possible medicinal benefits behind other medicinal plants has also expanded…
Health Law Prof Blog
What Psychedelic Practitioners Can Learn from Eye Surgeons About ‘Soft Furniture’ Method Patent Reform
Laurel Kilgour, What Psychedelic Practitioners Can Learn from Eye Surgeons About 'Soft Furniture' Method Patent Reform (2023):The article proposes targeted patent reform tailored to the emerging field of psychedelic facilitation,…
Israel Global Gateway
FDA issues draft guidance for clinical investigations of psychedelic drugs
By Israel Group
Against the backdrop of evolving state regulatory landscapes for controlled substances, including psychedelics for therapeutic uses, the US Food and Drug Administration (FDA) recently released a draft guidance entitled Psychedelic Drugs:…
Health Care Law Today
Key Takeaways from the FDA’s First Draft Guidance on Clinical Trials with Psychedelic Drugs
By Clara Greaney, Lauren P. Carboni, Monica R. Chmielewski, Kyle Y. Faget
On June 26, 2023, the U.S. Food and Drug Administration (FDA) issued its first draft guidance entitled Psychedelic Drugs: Considerations for Clinical Investigations Guidance for Industry (Guidance), which highlights considerations…
Budding Trends
Highly Legal: Will Congress Legalize Mushrooms Before Marijuana?
By Whitt Steineker, Hillary Campbell
We’ve been tossing this idea around in our heads ever since research about microdosing psychedelics entered the mainstream media a few years ago. And the more we think about it,…
Regulatory Oversight
FDA Issues Draft Guidance for Clinical Investigations of Psychedelic Drugs
By Agustin Rodriguez, Christina Sava, Ryan Graham
The Food and Drug Administration (FDA) recently issued first-of-its kind draft guidance for investigational new drug (IND) applications involving psychedelic drugs. Citing the rise in interest in exploring the potential…
Healthcare Law Insights
Analysis of U.S. Food and Drug Administration Draft Guidance on Clinical Trials with Psychedelic Drugs
By Paula Pastuskovas, Former Attorney Seth Mailhot, Kimberly Chew
On June 23, 2023 the U.S. Food and Drug Administration (FDA) published a draft guidance document with foundational considerations for researchers that are developing psychedelic drugs for the treatment of…
Life Sciences Perspectives
Psychedelics & Drug Development — Key Considerations for Healthcare Industry and Life Sciences Companies as Congress Seeks to Tap Into Psychedelics’ Therapeutic Potential
By Simone Otenaike|Alexander Varond|Julie Tibbets
Based on recent regulatory changes at the state and local level and the efforts by the federal government and certain foreign agencies, investors, clinical trial sponsors, life sciences companies, and…
Food Safety News
Clinical Tests coming after ‘magic mushrooms’ were legalized in Colorado
By Dan Flynn
The University of Colorado Anschutz Medical Campus in Aurora, CO, has announced the first modern-era psilocybin clinical trial for depression. The UC researchers will test whether psilocybin — the chemical…